Levy Adam D.
Acrivon Therapeutics, Inc. Common Stock · Chief Financial Officer
Levy Adam D. is listed in public filings as officer: Chief Financial Officer. This Levy Adam D. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Acrivon Therapeutics, Inc. Common Stock (ACRV). Investors use Levy Adam D.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --67.2k shares | Grant / ExerciseMay 18, 2026 | Disclosure amount unavailable46.2k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $201k132.9k shares | Grant / ExerciseMar 1, 2026 | $200.7K132.9k shares | $1.51 | -- | |
| $36k21k shares | BuyJan 14, 2026 | $15.0K8.8k shares | $1.70 | -- | |
| $15k12.2k shares | Grant / ExerciseAug 1, 2025 | $1.5K1.2k shares | $1.26 | -- | |
| $59k35.2k shares | Grant / ExerciseApr 1, 2025 | $59.2K35.2k shares | $1.68 | -- |